Renaissance Technologies
AXN

Renaissance Technologies’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Renaissance Technologies’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-114,920
Closed -$36K – 3505
2017
Q2 		$36K Buy
114,920
+27,600
+32% +$9.99K ﹤0.01% 3140
2017
Q1 		$35K Buy
87,320
+66,700
+323% +$28.7K ﹤0.01% 3161
2016
Q4 		$7K Buy
+20,620
New +$8.54K ﹤0.01% 3214
2015
Q2 		– Sell
-11,300
Closed -$19K – 3498
2015
Q1 		$19K Buy
+11,300
New +$10.5K ﹤0.01% 3117

Other funds holding AXN

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Renaissance Technologies's AXN Position: Q3 2017 in Review

Renaissance Technologies sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q3 2017, closing a stake of 114,920 shares — an estimated $36K sold.

Renaissance Technologies first reported a position in AXN in Q1 2015 and held it in 4 quarters. The position peaked at $36K in Q2 2017. 8 funds tracked by Wall St. Rank hold AXN as of Q3 2017.

  • Renaissance Technologies reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q3 2017 after selling out during the quarter.
  • Renaissance Technologies sold 114,920 Aoxing Pharmaceutical Company Inc. shares in Q3 2017, an estimated $36K.
  • Renaissance Technologies first reported a position in Aoxing Pharmaceutical Company Inc. in Q1 2015 and held it in 4 quarters.
  • Renaissance Technologies's Aoxing Pharmaceutical Company Inc. position peaked at $36K in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q3 2017.

Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.